Patients should maintain adequate hydration, especially if experiencing gastrointestinal side effects, to reduce the risk of acute kidney injury
Sources TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial New England Journal of Medicine American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking Symposium | American Diabetes Association Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial PMC NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
Our analyses suggest that the blood pressure benefits of GLP-1-based therapies are not exclusively driven by weight loss
Semaglutide is a medication primarily used to manage type 2 diabetes, but it has recently gained attention for its effectiveness in weight management
These include: maintaining adequate protein intake performing resistance or strength training supporting core stability addressing posture and spinal mechanics For patients who develop persistent spinal pain, evaluating whether the cause is muscular or disc related may help guide appropriate care
The formulations are functionally identical
